[1]
Hevonoja T, Pentikäinen MO, Hyvönen MT, Kovanen PT, Ala-Korpela M. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochimica et biophysica acta. 2000 Nov 15:1488(3):189-210
[PubMed PMID: 11082530]
Level 3 (low-level) evidence
[2]
Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Feingold KR. Introduction to Lipids and Lipoproteins. Endotext. 2000:():
[PubMed PMID: 26247089]
[4]
Walker HK, Hall WD, Hurst JW, Cox RA, García-Palmieri MR. Cholesterol, Triglycerides, and Associated Lipoproteins. Clinical Methods: The History, Physical, and Laboratory Examinations. 1990:():
[PubMed PMID: 21250192]
[5]
Kornilova ES. Receptor-mediated endocytosis and cytoskeleton. Biochemistry. Biokhimiia. 2014 Sep:79(9):865-78. doi: 10.1134/S0006297914090041. Epub
[PubMed PMID: 25385015]
[6]
Packard C, Caslake M, Shepherd J. The role of small, dense low density lipoprotein (LDL): a new look. International journal of cardiology. 2000 Jun 30:74 Suppl 1():S17-22
[PubMed PMID: 10856769]
[7]
Shimano H. SREBPs: physiology and pathophysiology of the SREBP family. The FEBS journal. 2009 Feb:276(3):616-21. doi: 10.1111/j.1742-4658.2008.06806.x. Epub
[PubMed PMID: 19143830]
[8]
Chandra A, Rohatgi A. The role of advanced lipid testing in the prediction of cardiovascular disease. Current atherosclerosis reports. 2014 Mar:16(3):394. doi: 10.1007/s11883-013-0394-9. Epub
[PubMed PMID: 24445969]
[9]
Bays HE, Jones PH, Orringer CE, Brown WV, Jacobson TA. National Lipid Association Annual Summary of Clinical Lipidology 2016. Journal of clinical lipidology. 2016 Jan-Feb:10(1 Suppl):S1-43. doi: 10.1016/j.jacl.2015.08.002. Epub
[PubMed PMID: 26891998]
[10]
Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Feingold KR. Utility of Advanced Lipoprotein Testing in Clinical Practice. Endotext. 2000:():
[PubMed PMID: 27099901]
Level 3 (low-level) evidence
[11]
Daniels TF, Killinger KM, Michal JJ, Wright RW Jr, Jiang Z. Lipoproteins, cholesterol homeostasis and cardiac health. International journal of biological sciences. 2009 Jun 29:5(5):474-88
[PubMed PMID: 19584955]
[12]
Rahman MS, Woollard K. Atherosclerosis. Advances in experimental medicine and biology. 2017:1003():121-144. doi: 10.1007/978-3-319-57613-8_7. Epub
[PubMed PMID: 28667557]
Level 3 (low-level) evidence
[13]
Miyajima C, Iwaki T, Umemura K, Ploplis VA, Castellino FJ. Characterization of Atherosclerosis Formation in a Murine Model of Type IIa Human Familial Hypercholesterolemia. BioMed research international. 2018:2018():1878964. doi: 10.1155/2018/1878964. Epub 2018 Jun 7
[PubMed PMID: 29977908]
[14]
Moin DS, Rohatgi A. Clinical applications of advanced lipoprotein testing in diabetes mellitus. Clinical lipidology. 2011 Aug 1:6(4):371-387
[PubMed PMID: 22162979]
[15]
Berberich AJ, Hegele RA. The complex molecular genetics of familial hypercholesterolaemia. Nature reviews. Cardiology. 2019 Jan:16(1):9-20. doi: 10.1038/s41569-018-0052-6. Epub
[PubMed PMID: 29973710]
[15]
The complex molecular genetics of familial hypercholesterolaemia., Berberich AJ,Hegele RA,, Nature reviews. Cardiology, 2018 Jul 4
[PubMed PMID: 29973710]
[16]
Yandrapalli S, Gupta S, Andries G, Cooper HA, Aronow WS. Drug Therapy of Dyslipidemia in the Elderly. Drugs & aging. 2019 Apr:36(4):321-340. doi: 10.1007/s40266-018-00632-x. Epub
[PubMed PMID: 30613912]
[17]
Monami M, Sesti G, Mannucci E. PCSK9 inhibitor therapy: A systematic review and meta-analysis of metabolic and cardiovascular outcomes in patients with diabetes. Diabetes, obesity & metabolism. 2019 Apr:21(4):903-908. doi: 10.1111/dom.13599. Epub 2018 Dec 21
[PubMed PMID: 30485622]
Level 1 (high-level) evidence